CTI BIOPHARMA CORP: capex
| Value | {"amount": 275000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2009-01-01 – 2009-06-30 |
| Status | current |
| Entity | CTI BIOPHARMA CORP |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cd6afc60-585d-4e60-8221-859b2bf9f5f2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-10-180853 · Open the official SEC filing →Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000891293/capex/2009-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cd6afc60-585d-4e60-8221-859b2bf9f5f2
History
- no predecessors — first report